Collaboration Details

Title of Collaborative Activity:

MOU with FDA in Clinical Proteomics

Description of Collaborative Activity:

CPTAC renewed its coordination with the FDA via a memorandum of understanding. This partnership provides regulatory science continuance on proteomic/proteogenomic analytical technologies, such 510(k) presubmissions. Partners include the Center for Devices and Radiological Health and Oncology Center of Excellence.

Type of Collaborative Activity:

Resource Development

Year the Collaborative Activity Originated:

2022

NIH Participating Institutes/Centers/Office of the Director:

HHS Agency Collaborators on this Activity:

FDA